Research and development of iPS cell-derived immuno-cell therapies with low immunogenicity
Company name
Shinobi Therapeutics Inc.
Type of business
Medical(medical devices, drug discovery)
Representatives
Daniel Kemp
Establishing a company
January 2023
Investment announcement date
December 2023
Capitalist
Hanae Suzuki
HP
https://shinobitx.comPhasing
Early
